Helius Medical Technologies Inc reports results for the quarter ended in March - Earnings Summary

Solana Co

11/05/2023 22:02

* Helius Medical Technologies Inc  HSDT.OQ  reported a
quarterly
adjusted loss of 9 cents​​ per share for the quarter ended in
March. The mean expectation of three analysts for the quarter
was for a loss of 11 cents per share.
    * Revenue fell 41.6% to $111.00 thousand from a year ago;
analysts
expected $283.33 thousand. 
    * Helius Medical Technologies Inc's reported EPS for the
quarter
was a loss of 9 cents​.
    * The mean earnings estimate of analysts had risen by
about 21.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Helius Medical Technologies Inc shares had fallen by 32.5%
this
quarter and lost 44.0% so far this year.
    * The company reported a quarterly loss of $2.49 million.
    * Wall Street's median 12-month price target for Helius
Medical
Technologies Inc is $2.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.11          -0.09          Beat
 Dec. 31 2022      -0.13          -0.17          Missed
 Sep. 30 2022      -0.21          -0.03          Beat
 Jun. 30 2022      -1.12          -0.97          Beat